AML3D completes commissioning of first two ARCEMY X systems at Newport News Shipbuilding, triggers final payment

AML3D has completed commissioning of the first two custom ARCEMY X large-scale metal additive manufacturing systems at Newport News Shipbuilding (NNS), a division of HII and the largest US military shipbuilder. The milestone triggers a final payment of approximately US$892,000, closing out the initial two-system order. Each system uses a 10,886 kg positioner for heavy-capacity shipbuilding applications. AML3D also reiterated that a follow-on order for four additional custom ARCEMY X systems, valued at about US$9.9 million, remains on track for delivery in early 2027 from the company's Stow, Ohio facility.

This commissioning represents a concrete execution marker within the US defense shipbuilding ecosystem, specifically the US Navy's Marine Industrial Base (MIB) demand theme. The ARCEMY X is a wire-fed directed energy deposition (DED) system, a process segment well-suited for large-scale, near-net-shape components in naval applications where lead time reduction and supply chain resilience are priorities. The NNS program sits alongside AML3D's other US Navy engagements, including an ARCEMY X 6700 at FasTech, a portable unit at the US Navy Additive Manufacturing Centre of Excellence in Danville, Virginia, and a BlueForge Alliance order for five non-safety-critical submarine replacement components. A US Navy letter of intent indicating a need for up to 100 AM systems and 3,400 additively manufactured parts by 2030 provides broader demand context, though it remains a non-binding signal rather than a firm order book. The key editorial lesson here is that defense-driven AM adoption is moving from pilot programs to fleet-level deployment, but the qualification and production scaling burden remains significant.

For AML3D, the immediate execution priority is delivering the four-system follow-on order on time while scaling production at Stow, Ohio, where the company has planned a A$12 million capacity-doubling investment. The company reported A$9.17 million in cash as of December 2025, with a net loss of A$4.97 million and operating cash outflow of A$2.27 million for the half, making manufacturing execution and cash management critical. With 87% of first-half 2026 revenue coming from US customers, concentration risk is real. The practical question is whether AML3D can convert the NNS validation into repeatable, cost-effective production without overextending its balance sheet.